World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking National Ranking Publications Citations
Immunology 158 90 58 579 91066
Medicine 158 860 491 576 91241

Joost J. Oppenheim publications per year

The chart shows the history of publications by Joost J. Oppenheim between 1964 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Joost J. Oppenheim published across 62 years, from 1964 to 2025, averaging 9.8 papers a year. Output peaked at 21 publications in 1985. 4 of the 607 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1964 to 2025. Vertical axis: number of publications, 0 to 21. Peak 21 publications in 1985. 1964: 1 publication 1965: 5 publications 1966: 4 publications 1967: 2 publications 1968: 2 publications 1969: 2 publications 1970: 6 publications 1971: 4 publications 1972: 15 publications 1973: 8 publications 1974: 15 publications 1975: 4 publications 1976: 14 publications 1977: 5 publications 1978: 6 publications 1979: 11 publications 1980: 11 publications 1981: 10 publications 1982: 14 publications 1983: 10 publications 1984: 8 publications 1985: 21 publications 1986: 14 publications 1987: 11 publications 1988: 14 publications 1989: 14 publications 1990: 12 publications 1991: 8 publications 1992: 10 publications 1993: 20 publications 1994: 7 publications 1995: 12 publications 1996: 10 publications 1997: 10 publications 1998: 10 publications 1999: 19 publications 2000: 13 publications 2001: 16 publications 2002: 20 publications 2003: 16 publications 2004: 14 publications 2005: 16 publications 2006: 14 publications 2007: 12 publications 2008: 12 publications 2009: 6 publications 2010: 15 publications 2011: 14 publications 2012: 4 publications 2013: 8 publications 2014: 13 publications 2015: 6 publications 2016: 9 publications 2017: 7 publications 2018: 5 publications 2019: 7 publications 2020: 5 publications 2021: 3 publications 2022: 5 publications 2023: 14 publications 2024: 2 publications 2025: 2 publications
1964 2025

607 publications in total across all disciplines

View publications per year as a table
Joost J. Oppenheim: publications per year, 1964 to 2025
Year Publications
1964 1
1965 5
1966 4
1967 2
1968 2
1969 2
1970 6
1971 4
1972 15
1973 8
1974 15
1975 4
1976 14
1977 5
1978 6
1979 11
1980 11
1981 10
1982 14
1983 10
1984 8
1985 21
1986 14
1987 11
1988 14
1989 14
1990 12
1991 8
1992 10
1993 20
1994 7
1995 12
1996 10
1997 10
1998 10
1999 19
2000 13
2001 16
2002 20
2003 16
2004 14
2005 16
2006 14
2007 12
2008 12
2009 6
2010 15
2011 14
2012 4
2013 8
2014 13
2015 6
2016 9
2017 7
2018 5
2019 7
2020 5
2021 3
2022 5
2023 14
2024 2
2025 2
Total 607
Download as CSV

Joost J. Oppenheim publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Joost J. Oppenheim sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 572–581 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 579 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17 579
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Joost J. Oppenheim D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Joost J. Oppenheim sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 157+ D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 158 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96 158
Download as CSV

Overview

Joost J. Oppenheim was affiliated with the National Institutes of Health in the United States. Their research primarily focused on immunology, molecular biology, and medicine, with a significant emphasis on subfields such as immunology, oncology, molecular biology, neurology, and cellular and molecular neuroscience.

The main scientific topics covered in their work included:

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • RNA Interference and Gene Delivery
  • Chemokine receptors and signaling
  • T-cell and B-cell Immunology
  • Cancer Research and Treatments

Their most frequent co-authors were:

  • De Yang
  • Md Masud Alam
  • Kouji Matsushima
  • Xiaoqing Li
  • Anna Trivett

Oppenheim published mainly in the following venues:

  • The Journal of Immunology
  • IUPHAR/BPS Guide to Pharmacology CITE
  • Cytokine
  • Cell Reports
  • International Immunopharmacology

Some of their recent research papers included:

  • "Interleukin-8: An evolving chemokine", 2022, Cytokine
  • "Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function", 2022, Cell Reports
  • "A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer", 2021, International Immunopharmacology
  • "Cytidine acetylation yields a hypoinflammatory synthetic messenger RNA", 2021, Cell chemical biology
  • "Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells", 2021, Cancer Immunology Research

Best Publications

  • β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6

    D. Yang;O. Chertov;S. N. Bykovskaia;Q. Chen

  • International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors

    Philip M. Murphy;Marco Baggiolini;Israel F. Charo;Caroline A. Hébert

  • Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine Family

    J. J. Oppenheim;C. O. C. Zachariae;N. Mukaida;K. Matsushima

  • Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells

    De Yang;Qian Chen;Albert P. Schmidt;G. Mark Anderson

  • There is more than one interleukin 1.

    Joost J. Oppenheim;Elizabeth J. Kovacs;Kouji Matsushima;Scott K. Durum

  • Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.

    Kouji Matsushima;Kazuhiro Morishita;Teizo Yoshimura;Sukadev Lavu

  • Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines

    Teizo Yoshimura;Kouji Matsushima;Shuji Tanaka;Elizabeth A. Robinson

  • The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.

    Christian Grønhøj Larsen;Arthur O. Anderson;Ettore Appella;Joost J. Oppenheim

  • Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2

    Arya Biragyn;Pier Adelchi Ruffini;Cynthia A. Leifer;Elena Klyushnenkova

  • Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line

    K Matsushima;C G Larsen;G C DuBois;J J Oppenheim

  • Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.

    Rosalba Salcedo;Maria Lourdes Ponce;Howard A. Young;Ken Wasserman

  • Alarmins: chemotactic activators of immune responses.

    Joost J Oppenheim;De Yang

  • Mammalian defensins in immunity: more than just microbicidal.

    De Yang;Arya Biragyn;Larry W Kwak;Joost J Oppenheim

  • Recombinant Human Interferon-inducible Protein 10 Is a Chemoattractant for Human Monocytes and T Lymphocytes and Promotes T Cell Adhesion to Endothelial Cells

    Dennis D. Taub;Andrew R. Lloyd;Kevin Conlon;Ji Ming Wang

  • Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta

    Dennis D. Taub;Kevin Conlon;Andrew R. Lloyd;Joost J. Oppenheim

  • Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF.

    Kouji Matsushima;Joost J. Oppenheim

  • Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

    Teizo Yoshimura;Kouji Matsushima;Joost J Oppenheim;Edward J Leonard

  • Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial Cells: In Vivo Neovascularization Induced by Stromal-Derived Factor-1α

    Rosalba Salcedo;Ken Wasserman;Howard A. Young;Michael C. Grimm

  • The functional relationship of the interleukins.

    Kendall A. Smith;Lawrence B. Lachman;Joost J. Oppenheim;Margaret F. Favata

  • Interleukin 1: an immunological perspective.

    Scott K. Durum;John A. Schmidt;Joost J. Oppenheim

  • Multiple Roles of Antimicrobial Defensins, Cathelicidins, and Eosinophil-Derived Neurotoxin in Host Defense*

    De Yang;Arya Biragyn;David M. Hoover;Jacek Lubkowski

Frequent Co-Authors

De Yang
De Yang National Cancer Research Institute, UK
Xin Chen
Xin Chen University of Macau
Kouji Matsushima
Kouji Matsushima Tokyo University of Science
O. M. Zack Howard
O. M. Zack Howard National Institutes of Health
Ji Ming Wang
Ji Ming Wang National Institutes of Health
David L. Rosenstreich
David L. Rosenstreich National Institutes of Health
Andrew R. Lloyd
Andrew R. Lloyd University of New South Wales
Dennis D. Taub
Dennis D. Taub George Washington University
Dan L. Longo
Dan L. Longo Harvard University
Stephan E. Mergenhagen
Stephan E. Mergenhagen National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in applying their Immunology background towards healthcare, pursuing advanced nursing roles can be a valuable pathway. Programs like the top psychiatric mental health nurse practitioner programs online offer flexible learning combined with high-quality clinical placements, making it easier to balance education and practical experience.

Cost is often a crucial factor when choosing the right program. Exploring the cheapest pmhnp certificate programs can help prospective students find accredited routes that fit their budget without compromising education standards.

Career advancement in nursing also includes understanding salary prospects. The dnp salary by state resource provides valuable insights into how earnings can vary geographically, helping graduates make informed decisions about where to work.

Additionally, nurses considering shifts in specialization can learn practical steps such as how to transition from FNP to acute care NP, opening up new clinical roles and opportunities. This transition is well detailed in the fnp to acute care np guide, which outlines the coursework and certifications needed to succeed.

Best Scientists Citing Joost J. Oppenheim

Recently Published Articles